Vimarsana
Biggest News Aggregation in the World

Page 32 - James Larkin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James Larkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Larkin Today - Breaking & Trending Today

Neoadjuvant Anti-PD-1 Strategy Prevails Over Adjuvant in Resectable Melanoma - Vimarsana News

Neoadjuvant Anti-PD-1 Strategy Prevails Over Adjuvant in Resectable Melanoma

Large increase in event-free survival with neoadjuvant plus adjuvant versus only adjuvant therapy

Not Just What, But When: Neoadjuvant Pembrolizumab in Melanoma - Vimarsana News

Not Just What, But When: Neoadjuvant Pembrolizumab in Melanoma

New trial results show that pembrolizumab given both before and after surgery for stage 2B-3 melanoma improved event-free survival compared with adjuvant therapy alone.

Could radioactive rhino horns prevent poaching? - Vimarsana News

Could radioactive rhino horns prevent poaching?

Poachers have been decimating the rhino population for years but a professor from Wits University believes radioactive technology could help.

Source: 702.co.za
'Striking' Colon Cancer Data Spur Mid-Presentation Ovation at ESMO - Vimarsana News

'Striking' Colon Cancer Data Spur Mid-Presentation Ovation at ESMO

Preoperative immunotherapy combo in dMMR disease yields major pathologic response in 95%

'Unprecedented' Responses to Neoadjuvant Tx in dMMR Colon Cancer - Vimarsana News

'Unprecedented' Responses to Neoadjuvant Tx in dMMR Colon Cancer

An 'innovative' study of short-course nivolumab plus ipilimumab prior to resection of MMR-deficient colon cancer has achieved 'unprecedented' pathologic responses, with no recurrences.